Rapid molecular epidemiology investigations into two recent measles outbreaks in Israel detected from October 2023 to January 2024-Reference-Cited by-同舟云学术

Rapid molecular epidemiology investigations into two recent measles outbreaks in Israel detected from October 2023 to January 2024

Published:2024-04-18 Issue:16 Volume:29 Page:
ISSN:1560-7917
Container-title:Eurosurveillance
language:en
Short-container-title:

Author:

Bucris Efrat¹²,Indenbaum Victoria¹²,Levin Tal²,Kanaaneh Yara²,Friedman Keren²,Kushnir Tatyana²,Sheffer Rivka³,Savion Michal³,Salama Matanelle³,Di-castro Noa⁴,Labay Kozita⁴,Butera Maya⁴,Shihada Baraah⁴,Mor Zohar⁵⁶,Lustig Yaniv¹⁷²,Zuckerman Neta S.¹²

Affiliation:

1. These authors contributed equally to the manuscript

2. Central Virology Laboratory, Public Health Services, Ministry of Health and Sheba Medical Center, Ramat-Gan, Israel

3. Tel Aviv District Health Office, Ministry of Health, Tel Aviv, Israel

4. District Health Office, Ministry of Health, Tiberias, Israel

5. School of Health Sciences, Ashkelon Academic College, Ashkelon, Israel

6. Division of Epidemiology, Ministry of Health, Jerusalem, Israel

7. Faculty of Medicine, Department of Epidemiology and Preventive Medicine, Tel-Aviv University, Tel Aviv, Israel

Abstract

Between late 2023 and early 2024, two measles outbreaks occurred in Israel, each caused by importation of measles virus strains of respective B3 and D8 genotypes. In this study, we validate transmission pathways uncovered by epidemiological investigations using a rapid molecular approach, based on complete measles virus genomes. The presented findings support this rapid molecular approach in complementing conventional contact tracing and highlight its potential for informing public health interventions.

Publisher

European Centre for Disease Control and Prevention (ECDC)

Reference9 articles.

1. A prolonged, nationwide measles outbreak despite very high vaccination coverage in Israel, 2018-19.;Anis;J Infect,2021

2. World Health Organization (WHO). "Eliminating measles and rubella in the WHO European Region" in the description of the outbreaks. p. 15. WHO Regional Office for Europe: Copenhagen. 2024. Available from: https://www.who.int/europe/publications/i/item/9789289060783

3. Mulders MN. “Annex B11.2 Real-time RT-PCR Assays for the Detection of Measles Virus (MeV) N Gene RNA and Human RNase P mRNA (a cellular reference gene) using the ABI 7500 Real-Time Thermocycler”. [Accessed 1 Apr 2024]. Available from: https://www.technet-21.org/en/resources/guidance/annex-b11-2-real-time-rt-pcr-assays-for-the-detection-of-measles-virus-mev-n-gene-rna-and-human-rnase-p-mrna-a-cellular-reference-gene-using-the-abi-7500-real-time-thermocycler

4. Genetic diversity of wild-type measles viruses and the global measles nucleotide surveillance database (MeaNS).;Wkly Epidemiol Rec,2015

5. Assessment of the Utility of Whole Genome Sequencing of Measles Virus in the Characterisation of Outbreaks.;Penedos;PLoS One,2015